Skip to content

Interest Paid at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$10.4M-20.9%
AbbVie logo
AbbVieABBV
$750.5M+6.8%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$0
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$20.12M+29.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$65K-15.6%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$1.49M+11.8%

Other financials

Income statement

See full
Revenue$17.0M-39.3%
Operating income-$134.0M-9.8%
Net income-$128.0M-14.3%
EPS (diluted)-$1.02+10.5%

Balance sheet

See full
Cash & equivalents$201.0M+4.7%
Total debt$113.0M+88.3%
Total equity$524.0M-1.3%
Total assets$997.0M-13.8%

Cash flow

See full
Operating cash flow-$138.0M-4.5%
CapEx--100%
Free cash flow-$138.0M-3.8%

Valuation

See full
Market cap$3.54B+226%
Enterprise value$3.46B+275%
P/S15×+7.3×

Profitability

See full
Operating margin-168.6%-52.7pp
Net margin-156.4%-47.5pp
FCF margin-207.2%

Returns & leverage

See full
Return on equity-70%+8.4pp
Debt / equity0.2×+0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Arcus Biosciences’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcus Biosciences's interest paid?
Arcus Biosciences (RCUS) reported interest paid of $1.75M in Q4 2025.
How has Arcus Biosciences's interest paid changed year-over-year?
Arcus Biosciences's interest paid increased by 600.0% year-over-year, from $250K to $1.75M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.